Skip to main content
. 2023 Aug 25;8:128. doi: 10.1038/s41541-023-00718-7

Fig. 1. Cost-effectiveness modeling framework.

Fig. 1

The health impact estimates from the Strep A vaccine impact model and the cost-of-illness estimates from economic burden study are inputs to the global cost-effectiveness analysis of prospective Strep A vaccines. The figure is adapted from “Giannini F et al. Modeling the potential health impact of prospective Strep A vaccines. NPJ Vaccines, 202317.